{"database": "lobbying", "table": "lobbying_activities", "rows": [[3140334, "3e438790-a4e6-4c9e-812e-f03e3f1163a6", "Q1", "INLET STRATEGIES", 401106604, "SECURING AMERICA'S MEDICINES AND SUPPLY SAMS", 2024, "first_quarter", "MMM", "Issues related to drug shortages and the pharmaceutical supply chain Reauthorization of the Pandemic and All-Hazards Preparedness The American Made Pharmaceuticals Act", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 37500, null, 0, 0, "2024-04-07T19:07:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3140334"], "units": {}, "query_ms": 0.45898200005467515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}